Drug Type Small molecule drug |
Synonyms FDC metoprolol/telmasartan, Telmasartan/S-metoprolol + [1] |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), β1-adrenergic receptor agonists(Beta-1 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date IN (01 Jan 2011), |
Regulation- |
Molecular FormulaC33H30N4O2 |
InChIKeyRMMXLENWKUUMAY-UHFFFAOYSA-N |
CAS Registry144701-48-4 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Essential Hypertension | IN | 01 Jan 2011 |